These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2603820)

  • 1. Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Adv Exp Med Biol; 1989; 247A():539-44. PubMed ID: 2603820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Biochem Biophys Res Commun; 1988 Jan; 150(1):511-6. PubMed ID: 3337729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of [hydroxyproline3]-bradykinin released from human plasma and plasma protein Cohn's fraction IV-4 by trypsin.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Biochem Biophys Res Commun; 1988 Nov; 157(1):210-7. PubMed ID: 3196332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
    Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
    Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of [hydroxyproline3]-lysyl-bradykinin released from human kininogens by human urinary kallikrein.
    Maier M; Reissert G; Jerabek I; Lottspeich F; Binder BR
    FEBS Lett; 1988 May; 232(2):395-8. PubMed ID: 3378631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
    Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
    Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new kinin moiety in human plasma kininogens.
    Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
    Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of a vasoactive peptide related to lysyl-bradykinin from trout plasma.
    Conlon JM; Olson KR
    FEBS Lett; 1993 Nov; 334(1):75-8. PubMed ID: 8224232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
    Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
    Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new kinin in human urine.
    Mindroiu T; Scicli G; Perini F; Carretero OA; Scicli AG
    J Biol Chem; 1986 Jun; 261(16):7407-11. PubMed ID: 3635531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification, isolation and structural determination of bradykinin and hydroxyprolyl-bradykinin in tumor ascites.
    Matsumura Y; Kimura M; Kato H; Yamamoto T; Maeda H
    Adv Exp Med Biol; 1989; 247A():587-92. PubMed ID: 2640567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of kinins on angiotensin I conversion in the local circulation.
    Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Clin Exp Hypertens A; 1990; 12(4):551-69. PubMed ID: 2196127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyp3]-bradykinin and [Hyp3]-Lys-bradykinin interact with B2-bradykinin receptors and stimulate inositol phosphate production in cultured human fibroblasts.
    Dengler R; Faussner A; Müller-Esterl W; Roscher AA
    FEBS Lett; 1990 Mar; 262(1):111-4. PubMed ID: 2156727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
    Oliveira EB; Martins AR; Camargo AC
    Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
    Gomes RA; Juliano L; Chagas JR; Hial V
    Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.